ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Hematology Oncology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,951Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 60

$3.18M Total Retail Price of All Prescriptions

Rank: 1 out of 60

277 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

44% of this provider’s 277 patients filled at least one prescription for a schedule two drug, compared to an average of 15%.

Schedule Three
Controlled Substances

45% of this provider’s 277 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 3,586 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$245 was the average price of a prescription from this provider, compared to $394 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 741 207 S3 1 2
OXYCODONE HCL 636 144 S2 2 9
GABAPENTIN 343 136 3 15
OMEPRAZOLE 300 86 4 10
LYRICA 275 62 5 26
HUMIRA 252 167 6 27
MELOXICAM 249 68 7 28
FUROSEMIDE 242 67 8 21
MORPHINE SULFATE ER 230 17 S2 9 19
SPIRIVA 225 59 10 29
CYMBALTA 208 48 11 31
SINGULAIR 196 53 12 33
ZOLPIDEM TARTRATE 189 27 13 22
PROAIR HFA 179 42 14 34
OXYCONTIN 176 41 S2 15 25
POTASSIUM CHLORIDE 176 66 15 7
METHOTREXATE 168 57 17 36
PRAMIPEXOLE DIHYDROCHLORIDE 160 37 18 37
PREDNISONE 158 60 19 8
MONTELUKAST SODIUM 151 25 20 38
FENTANYL 148 13 S2 21 16
LISINOPRIL 141 44 22 40
PROMETHAZINE HCL 135 20 R 23 23
LAMOTRIGINE 134 0 24 41
AMPHETAMINE SALT COMBO 125 0 S2 25 44
SAVELLA 116 25 26 46
FLUTICASONE PROPIONATE 115 39 27 47
MIRTAZAPINE 113 43 28 49
ADVAIR DISKUS 109 0 29 50
DEXILANT 108 0 30 51
TRAZODONE HCL 107 19 31 52
LEVOTHYROXINE SODIUM 107 28 31 13
METOCLOPRAMIDE HCL 106 32 33 53
ACTEMRA 99 48 10 34 54
AMLODIPINE BESYLATE 97 41 35 55
NEXIUM 94 31 36 39
METFORMIN HCL 93 30 37 56
ESCITALOPRAM OXALATE 89 0 38 58
ROPINIROLE HCL 88 30 39 59
TRAMADOL HCL 87 49 40 60
TOPIRAMATE 86 0 41 61
CARISOPRODOL 83 0 R 42 62
ATENOLOL 81 39 43 63
DOXAZOSIN MESYLATE 75 34 44 65
SIMVASTATIN 74 29 45 66
TRIAMCINOLONE ACETONIDE 74 19 45 66
SPIRONOLACTONE 73 0 47 68
AZATHIOPRINE 69 19 48 70
HYDROXYCHLOROQUINE SULFATE 68 50 49 71
OPANA ER 68 13 S2 49 71
METOPROLOL TARTRATE 68 24 49 71
LIDODERM 67 0 52 74
METHADONE HCL 64 23 S2 53 75
BUPROPION XL 62 21 54 77
METOPROLOL SUCCINATE 61 22 55 78
CYCLOBENZAPRINE HCL 60 16 R 56 79
HYDROCHLOROTHIAZIDE 59 21 57 81
LANTUS SOLOSTAR 58 14 58 82
ATORVASTATIN CALCIUM 57 22 59 83
FLUOXETINE HCL 54 13 60 84
ABILIFY 54 0 60 84
NAMENDA 54 28 60 84
MORPHINE SULFATE 54 0 S2 60 84
CARVEDILOL 51 23 64 88
JANUMET 51 0 64 88
PEN NEEDLE 50 11 66 91
TIZANIDINE HCL 50 0 66 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.